ERBB2 and ovarian serous adenocarcinoma: One patient (patient 17, DL 20 × 106) with high-grade serous ovarian cancer (HER2 IHC 3+, FISH 1.3) had lesions confined to the vaginal cuff at the time of enrollment that completely regressed after four doses of vaccine.